ENTITY
3SBio

3SBio (1530 HK)

196
Analysis
Health Care • China
3SBio is a leading biotechnology company engaged in the research, development, manufacturing, and marketing of biopharmaceutical products. The company's diverse portfolio addresses therapeutic areas such as nephrology, oncology, supportive cancer care, inflammation, infectious diseases, autoimmune diseases, metabolism, and dermatology, with key products including EPIAO and TPIAO. 3SBio was founded in 1993 and is headquartered in Shenyang, China.
more
•12 Sep 2016 23:18

Iran Shows China the Way on Population Expansion

Faced with dramatically falling birth rates, Iran has introduced a wide range of pro-natalist policies. In contrast, China has been half-hearted in...

Logo
360 Views
Share
bearish•Quantitative Analysis
•12 Apr 2026 10:05

HK Connect Flows Weekly (Apr 10th): CNOOC, YOFC, AIA, China Life, Xiaomi, Alibaba, 3Sbio

We analyzed southbound Hong Kong connect flows in the past week and highlighted flows for CNOOC, YOFC, AIA, China Life, Xiaomi, Alibaba, 3Sbio,...

Logo
284 Views
Share
•18 Aug 2016 18:43

Small Improvement in China Air Quality

Air quality in China appears to have improved slightly in recent months. However, it is still well above World Health Organisation recommended...

Logo
387 Views
Share
•04 Aug 2016 16:39

Critique of Genome Scientific Work

China’s state media reported this week that Han Chunyu’s scientific results on genome editing which were published in Nature Biotechnology in May...

Logo
392 Views
Share
•04 Aug 2016 16:05

China's Disconnect on Illegal Drugs

Senior Chinese officials regularly make all the appropriate noises about the evils of illicit drug use in China, but they seem unable to do...

Logo
814 Views
Share
x